Related Experiment Video
Updated: May 25, 2026
02:28
Measuring Psoriasis Severity at Home
Published on: March 1, 2024
[Prognostic factors in psoriatic arthritis]
José Luis Fernández Sueiro1, José Manuel Lema Gontad
1INIBIC, Servicio de Reumatología, Complejo Hospitalario Universitario de A Coruña, A Coruña, España. L.sueiro@canalejo.org
Reumatologia Clinica
|January 20, 2012
Summary
Peripheral psoriatic arthritis significantly impacts quality of life, similar to other chronic joint diseases. Despite treatments, many patients do not achieve remission, highlighting the need for close monitoring and effective management.
Area of Science:
- Rheumatology
- Immunology
- Inflammatory Diseases
Context:
- Peripheral psoriatic arthritis (PsA) is a chronic, progressive inflammatory condition.
- PsA imposes a substantial burden on structural integrity, physical function, and quality of life.
- The disease burden is comparable to other chronic polyarthritides.
Purpose:
- To review the clinical implications of peripheral psoriatic arthritis.
- To emphasize the challenges in achieving remission with current therapies.
- To underscore the importance of diligent patient follow-up and management.
Summary:
- Peripheral psoriatic arthritis presents a significant disease burden, affecting joint structure, function, and quality of life.
- Current treatments, including synthetic and biologic disease-modifying antirheumatic drugs (DMARDs), achieve remission in only approximately 30% of patients.
- Persistent joint activity, characterized by tender and swollen joints, is a key driver of progressive joint damage.
Impact:
- Highlights the unmet need for improved therapeutic strategies in psoriatic arthritis.
- Emphasizes the critical role of continuous patient monitoring to prevent irreversible joint damage.
- Informs clinical practice regarding the management of chronic inflammatory joint diseases.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...